Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these receptors, https://reganajqf761429.actoblog.com/36909665/tirzepatide-a-promising-new-treatment-for-obesity